# Diterpenoids and triterpenoids from the roots of Tripterygium regelii and their inhibitory effects on colorectal cancer cells

**Authors:** Ping Guo, Jianming Yu, Qi Zhao, Jintao Sun, Rongxin Lin, Linlin Sui, Aijing Leng, Chao Wang, Shuo Wang, Dawei Li

PMC · DOI: 10.3389/fchem.2026.1784072 · 2026-02-20

## TL;DR

Researchers found new compounds in Tripterygium regelii roots that may help fight colorectal cancer by causing cell damage.

## Contribution

The discovery of a new triterpenoid and two new diterpenoids with anti-cancer properties.

## Key findings

- Compound 2 shows antiproliferative activity against colorectal cancer cells.
- Compound 2 induces ROS generation, lipid peroxidation, and mitochondrial damage.
- Compound 2 promotes ferroptosis in colorectal cancer cells.

## Abstract

A total of 22 terpenoids including one new triterpenoid (1), two new diterpenoids (2 and 3), and 19 known compounds (4–22) were isolated from the roots of Tripterygium regelii. Their structures were identified using NMR and HRESIMS techniques. Antiproliferative activity screening assays revealed that the new compound 2, along with several known compounds, exhibits potential anti-colorectal cancer efficacy. Further investigations employing flow cytometry, immunofluorescence staining and electron microscopy demonstrated that compound 2 induces the generation of reactive oxygen species (ROS). This, in turn, promotes lipid peroxidation and mitochondrial damage, ultimately enhancing ferroptosis in colorectal cancer cells. These findings underscore the value of compound 2 as a potential candidate for anti-tumor drug development.

## Linked entities

- **Chemicals:** compound 2 (PubChem CID 5494425)
- **Diseases:** colorectal cancer (MONDO:0005575)
- **Species:** Tripterygium regelii (taxon 123485)

## Full-text entities

- **Genes:** SLC7A11 (solute carrier family 7 member 11) [NCBI Gene 23657] {aka CCBR1, xCT}, DR1 (down-regulator of transcription 1) [NCBI Gene 1810] {aka NC2, NC2-BETA, NC2B, NCB2}, SLC3A2 (solute carrier family 3 member 2) [NCBI Gene 6520] {aka 4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1}, GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}
- **Diseases:** cytotoxic (MESH:D064420), malignancies (MESH:D009369), CRC (MESH:D015179), nephrotic syndrome (MESH:D009404), Mitochondrial (MESH:D028361), rheumatoid arthritis (MESH:D001172), inflammatory (MESH:D007249), systemic lupus erythematosus (MESH:D008180), autoimmune and inflammatory diseases (MESH:D001327)
- **Chemicals:** celastrol (MESH:C050414), C (MESH:D002244), acetone (MESH:D000096), uranyl acetate (MESH:C005460), CH3CN (MESH:C032159), ester (MESH:D004952), triptophenolide methyl ether (MESH:C035063), ketone (MESH:D007659), triterpenoid (MESH:D014315), trifluoroacetic acid (MESH:D014269), CH2Cl2 (MESH:D008752), lignans (MESH:D017705), osmium tetroxide (MESH:D009993), triptonoterpenol (MESH:C054162), silica (MESH:D012822), phosphate (MESH:D010710), triptoquinone A (MESH:C100591), crystal violet (MESH:D005840), CH3OH (MESH:D000432), triptophenolide (MESH:C035061), 22beta-acetylglabric acid (-), H3 (MESH:C012616), silica gel (MESH:D058428), 13C (MESH:C000615229), ROS (MESH:D017382), ethanol (MESH:D000431), flavonoids (MESH:D005419), Diterpenoids (MESH:D004224), glacial acetic acid (MESH:D019342), SDS (MESH:D012967), PVDF (MESH:C024865), H (MESH:D006859), PB (MESH:D007854), terpenoid (MESH:D013729), aluminum oxide (MESH:D000537), agarose (MESH:D012685), sesquiterpenoids (MESH:D012717), petroleum ether (MESH:C004544), DCFH-DA (MESH:C029569), Lipid (MESH:D008055), CO2 (MESH:D002245), CCK-8 (MESH:D012844), oleanane (MESH:C413246), H2O (MESH:D014867)
- **Species:** Homo sapiens (human, species) [taxon 9606], Tripterygium wilfordii (species) [taxon 458696], Tripterygium hypoglaucum (species) [taxon 205465], Tripterygium regelii (species) [taxon 123485]
- **Mutations:** C for 5-8, C for 2-4, S0043M, X500R, S0033M
- **Cell lines:** HT29 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0320), HCT116 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0291)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12962659/full.md

---
Source: https://tomesphere.com/paper/PMC12962659